The cost-effectiveness of screening for latent tuberculosis infection

Int J Tuberc Lung Dis. 2000 Dec;4(12 Suppl 2):S127-33.
No abstract available

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antitubercular Agents / economics*
  • Antitubercular Agents / therapeutic use
  • Child
  • Cost-Benefit Analysis
  • Decision Trees
  • Female
  • Humans
  • Male
  • Markov Chains
  • Mass Screening / economics*
  • Middle Aged
  • Models, Econometric
  • Quality-Adjusted Life Years
  • Tuberculosis / economics
  • Tuberculosis / prevention & control*
  • United States

Substances

  • Antitubercular Agents